Cargando…

Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study

BACKGROUND: Several mechanisms have been proposed to explain why chronic obstructive pulmonary disease (COPD) impairs the prognosis of coronary events. We aimed to explore COPD variables related to a worse prognosis in patients undergoing percutaneous coronary intervention (PCI). METHODS: Patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Komal, Diaz-Coto, Susana, de la Asunción Villaverde, Maria, Martinez-Camblor, Pablo, Navarro-Rolon, Annie, Pujalte, Francisco, De la Sierra, Alejandro, Almagro, Pere
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578359/
https://www.ncbi.nlm.nih.gov/pubmed/36267326
http://dx.doi.org/10.2147/COPD.S373853
_version_ 1784811955821740032
author Malik, Komal
Diaz-Coto, Susana
de la Asunción Villaverde, Maria
Martinez-Camblor, Pablo
Navarro-Rolon, Annie
Pujalte, Francisco
De la Sierra, Alejandro
Almagro, Pere
author_facet Malik, Komal
Diaz-Coto, Susana
de la Asunción Villaverde, Maria
Martinez-Camblor, Pablo
Navarro-Rolon, Annie
Pujalte, Francisco
De la Sierra, Alejandro
Almagro, Pere
author_sort Malik, Komal
collection PubMed
description BACKGROUND: Several mechanisms have been proposed to explain why chronic obstructive pulmonary disease (COPD) impairs the prognosis of coronary events. We aimed to explore COPD variables related to a worse prognosis in patients undergoing percutaneous coronary intervention (PCI). METHODS: Patients with an acute coronary event treated by PCI were prospectively included. One month after discharge, clinical characteristics, comorbidities measured with the Charlson index, and prognostic coronary scales (logistic EuroSCORE; GRACE 2.0) were collected. Post-bronchodilator spirometry, arterial stiffness, and serum inflammatory and myocardial biomarkers were measured. Lung plasmatic biomarkers (Surfactant protein D, desmosine, and Clara cell secretory protein-16) were determined with ELISA. COPD was defined by the fixed ratio (FEV1/FVC <70%). Spirometric values were also analyzed as continuous variables using adjusted and non-adjusted ANCOVA analysis. Finally, we evaluated the presence of a respiratory pattern defined by non-stratified spirometric values and pulmonary biomarkers. RESULTS: A total of 164 patients with a mean age of 65 (±10) years (79% males) were included. COPD was diagnosed in 56 (34%) patients (68% previously undiagnosed). COPD patients had a longer smoking history, higher scores on the EuroSCORE (p < 0.0001) and GRACE 2.0 (p < 0.001) scales, and more comorbidities (p = 0.006). Arterial stiffness determined by pulse wave velocity was increased in COPD patients (7.35 m/s vs 6.60 m/s; p = 0.006). Serum values of high sensitive T troponin (p = 0.007) and surfactant protein D (p = 0.003) were also higher in COPD patients. FEV1% remained significantly associated with arterial stiffness and surfactant protein D in the adjusted ANCOVA analysis. In the cluster exploration, 53% of the patients had a respiratory pattern. CONCLUSION: COPD affects one-third of patients with an acute coronary event and frequently remains undiagnosed. Several mechanisms, including arterial stiffness and SPD, were increased in COPD patients. Their relationship with the prognosis should be confirmed with longitudinal follow-up of the cohort.
format Online
Article
Text
id pubmed-9578359
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-95783592022-10-19 Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study Malik, Komal Diaz-Coto, Susana de la Asunción Villaverde, Maria Martinez-Camblor, Pablo Navarro-Rolon, Annie Pujalte, Francisco De la Sierra, Alejandro Almagro, Pere Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Several mechanisms have been proposed to explain why chronic obstructive pulmonary disease (COPD) impairs the prognosis of coronary events. We aimed to explore COPD variables related to a worse prognosis in patients undergoing percutaneous coronary intervention (PCI). METHODS: Patients with an acute coronary event treated by PCI were prospectively included. One month after discharge, clinical characteristics, comorbidities measured with the Charlson index, and prognostic coronary scales (logistic EuroSCORE; GRACE 2.0) were collected. Post-bronchodilator spirometry, arterial stiffness, and serum inflammatory and myocardial biomarkers were measured. Lung plasmatic biomarkers (Surfactant protein D, desmosine, and Clara cell secretory protein-16) were determined with ELISA. COPD was defined by the fixed ratio (FEV1/FVC <70%). Spirometric values were also analyzed as continuous variables using adjusted and non-adjusted ANCOVA analysis. Finally, we evaluated the presence of a respiratory pattern defined by non-stratified spirometric values and pulmonary biomarkers. RESULTS: A total of 164 patients with a mean age of 65 (±10) years (79% males) were included. COPD was diagnosed in 56 (34%) patients (68% previously undiagnosed). COPD patients had a longer smoking history, higher scores on the EuroSCORE (p < 0.0001) and GRACE 2.0 (p < 0.001) scales, and more comorbidities (p = 0.006). Arterial stiffness determined by pulse wave velocity was increased in COPD patients (7.35 m/s vs 6.60 m/s; p = 0.006). Serum values of high sensitive T troponin (p = 0.007) and surfactant protein D (p = 0.003) were also higher in COPD patients. FEV1% remained significantly associated with arterial stiffness and surfactant protein D in the adjusted ANCOVA analysis. In the cluster exploration, 53% of the patients had a respiratory pattern. CONCLUSION: COPD affects one-third of patients with an acute coronary event and frequently remains undiagnosed. Several mechanisms, including arterial stiffness and SPD, were increased in COPD patients. Their relationship with the prognosis should be confirmed with longitudinal follow-up of the cohort. Dove 2022-10-14 /pmc/articles/PMC9578359/ /pubmed/36267326 http://dx.doi.org/10.2147/COPD.S373853 Text en © 2022 Malik et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Malik, Komal
Diaz-Coto, Susana
de la Asunción Villaverde, Maria
Martinez-Camblor, Pablo
Navarro-Rolon, Annie
Pujalte, Francisco
De la Sierra, Alejandro
Almagro, Pere
Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study
title Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study
title_full Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study
title_fullStr Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study
title_full_unstemmed Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study
title_short Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study
title_sort impact of spirometrically confirmed chronic obstructive pulmonary disease on arterial stiffness and surfactant protein d after percutaneous coronary intervention. the catepoc study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578359/
https://www.ncbi.nlm.nih.gov/pubmed/36267326
http://dx.doi.org/10.2147/COPD.S373853
work_keys_str_mv AT malikkomal impactofspirometricallyconfirmedchronicobstructivepulmonarydiseaseonarterialstiffnessandsurfactantproteindafterpercutaneouscoronaryinterventionthecatepocstudy
AT diazcotosusana impactofspirometricallyconfirmedchronicobstructivepulmonarydiseaseonarterialstiffnessandsurfactantproteindafterpercutaneouscoronaryinterventionthecatepocstudy
AT delaasuncionvillaverdemaria impactofspirometricallyconfirmedchronicobstructivepulmonarydiseaseonarterialstiffnessandsurfactantproteindafterpercutaneouscoronaryinterventionthecatepocstudy
AT martinezcamblorpablo impactofspirometricallyconfirmedchronicobstructivepulmonarydiseaseonarterialstiffnessandsurfactantproteindafterpercutaneouscoronaryinterventionthecatepocstudy
AT navarrorolonannie impactofspirometricallyconfirmedchronicobstructivepulmonarydiseaseonarterialstiffnessandsurfactantproteindafterpercutaneouscoronaryinterventionthecatepocstudy
AT pujaltefrancisco impactofspirometricallyconfirmedchronicobstructivepulmonarydiseaseonarterialstiffnessandsurfactantproteindafterpercutaneouscoronaryinterventionthecatepocstudy
AT delasierraalejandro impactofspirometricallyconfirmedchronicobstructivepulmonarydiseaseonarterialstiffnessandsurfactantproteindafterpercutaneouscoronaryinterventionthecatepocstudy
AT almagropere impactofspirometricallyconfirmedchronicobstructivepulmonarydiseaseonarterialstiffnessandsurfactantproteindafterpercutaneouscoronaryinterventionthecatepocstudy